TPO-receptor agonists in ITP: A clinician's navigation between scylla and charybdis

American Journal of Hematology

Volumn 87, Issue 10, 2012, Pages 943-943

  Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; THROMBOPOIETIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

CONFLICT OF INTEREST; EVIDENCE BASED PRACTICE; HEALTH CARE NEED; HUMAN; IMMUNE THROMBOCYTOPENIA; METHODOLOGY; NOTE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

BENZOATES; CLINICAL TRIALS AS TOPIC; HEMORRHAGE; HUMANS; HYDRAZINES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOPOIETIN;

EID: 84866762761     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23301     Document Type: Note

References (1)

1. Zeng Y, Duan X, Xu J, Ni X. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. Cochrane Database Syst Rev 2011; (7): CD008235.